(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

GALACORIN

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

GALACORIN

ST13

US500000085836485

Class

1, 5

Filing

85836485

Registration

5050014

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

47

Latest update

09/28/2025

Trademark type

Word

Nice classes

1, 5

Filing date

01/30/2013

Registration date

09/27/2016

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/06/2023

Last transaction

09/28/2025

Responsible office

United States Patent and Trademark Office

Status code

702

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

12/15/2011

First use in commerce

12/15/2011

Drawing code

4

Owner type

03

Owner location

Somerset, NJ

Examiner

SAITO, KIM

Law office

L20

Current location

TMEG LAW OFFICE 102

Holders and representatives

Holders

CATALENT PHARMA SOLUTIONS, INC.

Representatives

Vanessa A. Ignacio, Esq. Lowenstein Sandler LLP

Technical classification

Nice Classes

Class 1Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Assays and reagents for use in genetic research; reagents for scientific or medical research use; protein arrays and nucleotide arrays for scientific and medical research; therapeutic proteins for scientific and medical research

Class 5

Biochemicalsproteins and decorin molecules for medical or veterinary purposes; therapeutic proteins for the prevention and treatment of a wide variety of human diseases and disorderscardiovascular diseasesstrokecentral nervous system diseases and disordersmetabolic disordersconnective tissue diseases and disordersdiabetesobesitycancerincontinenceinflammation and inflammatory diseasesrespiratory and infectious diseasesauto-immune diseasestransplant rejectionwound healing and tissue repair

Publications

History of USPTO decisions and trademark events.

47 publications found

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

09/27/2025

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

12/25/2024

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

04/06/2023

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

04/06/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

04/06/2023

E815

TEAS SECTION 8 & 15 RECEIVED

09/27/2022

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

09/27/2021

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

05/22/2019

R.PR

REGISTERED-PRINCIPAL REGISTER

09/27/2016

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

08/23/2016

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

08/22/2016

SUPC

STATEMENT OF USE PROCESSING COMPLETE

08/21/2016

IUAF

USE AMENDMENT FILED

08/16/2016

EISU

TEAS STATEMENT OF USE RECEIVED

08/16/2016

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

02/13/2016

EX4G

SOU EXTENSION 4 GRANTED

02/12/2016

EXT4

SOU EXTENSION 4 FILED

01/15/2016

EEXT

SOU TEAS EXTENSION RECEIVED

01/15/2016

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

07/21/2015

EX3G

SOU EXTENSION 3 GRANTED

07/18/2015

EXT3

SOU EXTENSION 3 FILED

07/09/2015

EEXT

SOU TEAS EXTENSION RECEIVED

07/09/2015

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

02/17/2015

EX2G

SOU EXTENSION 2 GRANTED

02/14/2015

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

02/12/2015

EXT2

SOU EXTENSION 2 FILED

12/22/2014

EEXT

SOU TEAS EXTENSION RECEIVED

12/22/2014

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

08/27/2014

EX1G

SOU EXTENSION 1 GRANTED

08/25/2014

EXT1

SOU EXTENSION 1 FILED

08/25/2014

EEXT

SOU TEAS EXTENSION RECEIVED

08/25/2014

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

02/25/2014

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/31/2013

PUBO

PUBLISHED FOR OPPOSITION

12/31/2013

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/11/2013

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

11/22/2013

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/21/2013

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/24/2013

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/24/2013

ALIE

ASSIGNED TO LIE

10/15/2013

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/11/2013

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

05/22/2013

GNRT

NON-FINAL ACTION E-MAILED

05/22/2013

CNRT

NON-FINAL ACTION WRITTEN

05/22/2013

DOCK

ASSIGNED TO EXAMINER

05/14/2013

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/05/2013

NWAP

NEW APPLICATION ENTERED

02/02/2013

Continuous trademark protection

Get notified about every new filing that threatens GALACORIN or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.